Company intelligence / Profile preview

ClouDr

Ownership: Private
Development stage: Other

Overview

ClouDr has rapidly scaled its hospital-based digital solutions for managing chronic diseases. By 2021, its software was installed in over 170,000 pharmacies across China—about 30% of all drugstores. The company generates most revenue from sales of medical supplies/devices and digital marketing to pharmaceutical companies. Its business model focuses on providing SaaS tools to hospitals/pharmacies for patient management and online consultation/prescription services. No clinical trial results apply as it is not a therapeutics developer.

Therapeutic areas: CardiovascularEndocrinology
Modalities: DeviceSoftwareDigital health service
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on ClouDr.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ClouDr.

Explore the full profile